The underwriters announced that the offering is cancelled and it remains unclear what will happen with the shares that have already been traded. Nasdaq stopped trading in the shares on Friday morning and it has not been renewed since.
VBL, managed by Dror Harats develops and markets drugs for the treatment of cancer and autoimmune diseases. During the IPO, which has not been completed,
(c)2014 the Globes (Tel Aviv, Israel)
Visit the Globes (Tel Aviv, Israel) at www.globes.co.il/serveen/globes/nodeview.asp?fid=942
Distributed by MCT Information Services